UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) ~~of the Securities Exchange Act of 1934~~

~~Date~~ of ~~Report~~the ~~(Date~~Securities ofExchange ~~earliest~~Act ~~event~~of ~~reported): March 18, 2026~~1934

Date of Report (Date of earliest event reported): March 17, 2026

Lifeward Ltd.

(Exact name of registrant as specified in its charter)

Israel	001-36612	Not applicable
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(IRS Employer Identification No.)

2 Cabot Rd., Hudson, MA		01749
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: +508.251.1154

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Exchange Act		Trading Symbol(s)		Name of each exchange on which registered
Ordinary Shares, no par value		LFWD		Nasdaq Capital Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Ordinary Shares, no par value		LFWD		Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 23.0201 ~~Results~~Notice of ~~Operations~~Delisting ~~and~~or ~~Financial~~Failure ~~Condition.~~to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

OnNasdaq ~~March~~Corporate ~~18,~~Governance ~~2026,~~Standard Lifeward Ltd. (the “Company,” “we” or “us”) issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2025. A copy of the press release is being furnished herewith as Exhibit 99.1. As set forth in the press release, the Company will host a conference call to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2025, on March 18, 2026 at 8:30 a.m. E.D.T. The archived webcast will be available at https://edge.mediaNon-~~server.com/mmc/p/yc9qmwr7.and/or through the Company’s website at www.golifeward.com under the “Investors” section for 30 days after the completion of the call.~~Compliance

~~The~~On ~~information~~March in17, ~~this~~2026, ~~Current~~Lifeward ~~Report~~Ltd. on(the ~~Form~~“Company”) ~~8-K,~~received ~~including~~a ~~Exhibit~~notice ~~99.1,~~(the ~~shall~~“Audit ~~not~~Committee ~~be deemed “filed~~Notice”) ~~for~~from ~~purposes~~the ~~of Section 18~~Nasdaq ofListing ~~the~~Qualifications ~~Securities~~Department ~~Exchange~~indicating ~~Act~~that, offollowing ~~1934,~~Hadar asLevy’s ~~amended~~resignation (from the ~~“1934~~Board ~~Act”),~~of ~~nor~~Directors ~~shall~~of itthe beCompany, ~~deemed~~which ~~“incorporated~~reduced bythe ~~reference”~~Audit ~~into~~Committee ~~any~~to ~~filing~~two ~~under~~members, the ~~Securities~~Company ~~Act~~no oflonger ~~1933,~~complies aswith ~~amended,~~the oraudit ~~the~~committee requirement ~~1934~~under ~~Act~~Nasdaq Listing Rule 5605(c)(2)(A), ~~except~~which asrequires ~~may~~listed becompanies ~~expressly~~to ~~set~~have ~~forth~~an ~~by specific~~audit ~~reference~~committee inof ~~such~~at ~~filing~~least three members.

~~Item~~The ~~9.01~~Company ~~Financial~~is ~~Statements~~in the process of reviewing and ~~Exhibits~~evaluating potential options to regain compliance with these continued listing requirements noted above in a manner consistent with the cure period set out in Nasdaq Listing Rule 5605(c)(4) of the Nasdaq rules. Such cure period provide that the Company will have until the earlier of its next annual meeting of shareholders or February 24, 2027; provided, however, that if the Company’s next annual meeting of shareholders is held before August 24, 2026, then the Company must evidence compliance no later than August 24, 2026. There can be no assurance that the Company will successfully regain compliance with these continued listing requirements within the applicable cure period.

(d) Exhibits
99.1	Press release dated March 18, 2026 of Lifeward Ltd., announcing financial results for the fourth quarter and fiscal year ended December 31, 2025.*
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).
*	Furnished herewith

The Audit Committee Notice does not have an immediate effect on the listing of the Company’s ordinary shares, and the ordinary shares will continue to trade on The Nasdaq Capital Market under the symbol “LFWD” at this time.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Lifeward Ltd.
Dated: March 18, 2026	By:	/s/ Almog Adar
Dated: March 20, 2026	By:	/s/ Almog Adar
	Name:	Almog Adar
	Title:	Chief Financial Officer

Filing Compare · Lifeward Ltd.